What’s Trending on PharmPro.com
AstraZeneca to Pay Millions to Settle Seroquel, Crestor
AstraZeneca will pay a total of $110 million to resolve allegations that
the company encouraged doctors to use the drugs for unapproved
uses—$90 million for Seroquel and $20 million for Crestor.
FDA Approves First Generic Under New Pathway to
Enhance Market Competition
The FDA approved several strengths of potassium chloride oral
solution as the first generic drugs to receive a Competitive Generic
Therapy (CGT) designation.
The $100 Million Biopharma Bombshell: The Cost of
Launching in the EU
Many American companies are unaware of the cost and complexity
involved in commercializing drugs in the EU, and don’t realize the
extent of the launch costs until it’s too late.
People on the Move
Thierry Dupoux, seasoned medical device professional, is the new
Senior Director of Quality Assurance at CARMAT • Wim Souverijns,
formerly with Celgene, has joined ObsEva as Chief Commercial
Officer • Dr. Fraser Wright, who has extensive gene therapy vector
manufacturing experience, has been appointed as Senior Advisor,
Yposkesi • Kelvyn H. Cullimore Jr., former President and CEO of
Dynatronics Corp., joins BioUtah as President and CEO • David Pernock
moved from Chief Commercial Officer to Chief Operating Officer at Eagle
Pharmaceuticals • Dr. Andrea Barthwell has been appointed Board
Chair at McKessen Corp., and Dr. Karen A. Scott will serve as President
of the Foundation for Opioid Response Efforts. • Brian Furmanski,
Ph.D. and Gene Williams, Ph.D., former FDA reviewers, join Nuventra
Pharma Sciences as Senior Consultants.
and Pharma Issues
"I'm not counting on their altruism or their
—Alex Azar, HHS Secretary, about pharma companies
at the Financial Times Pharma Pricing Summit.
Biosimilars & Pharmaceuticals 2019
Feb. 29-March 1
The conference will convey recent developments
in biosimilar drug marketing and production. Join
participants from around the world as they take part in
keynote presentations, workshops, and symposiums.
Pharma R&D 2019
The program brings together pharmaceutical scientists
and engineers from industry, academia, and regulatory
agencies to discuss recent developments and future
trends in the field of pharmaceutical product and
PITTCON 2019 Conference & Expo
The event provides a hands-on look at the latest
innovations and helps attendees find solutions to
Biosimilars & Biologics: Present Scenario &
Plunge further into the examination of the changing
biosimilar market at this event that focuses on the future
prospects of the industry.
New York, NY
A business development event for companies engaged
in pharmaceutical development and related industries.
New York, NY
Attend the annual event that explores pharmaceutical,
biotechnology, and device development and
manufacturing through exhibits, demonstrations, and
Pharmaceutical Research & Innovations in
The theme of the event is exploring the recent trends
and advances in the field of pharma research and
The number of states that have legalized
unrestricted use of medical marijuana.